These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10375279)

  • 1. Percutaneous ultrasound-guided radiofrequency ablation of liver tumors.
    Buscarini L; Buscarini E
    Liver Transpl Surg; 1999 May; 5(3):255-7. PubMed ID: 10375279
    [No Abstract]   [Full Text] [Related]  

  • 2. Local ablation therapy for hepatocellular carcinoma. From ethanol injection to radiofrequency ablation.
    Shiina S; Tateishi R; Yoshida H; Kanai F; Omata M
    Saudi Med J; 2007 Jun; 28(6):831-7. PubMed ID: 17530094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.
    Mahnken AH; Bruners P; Günther RW
    Dig Dis; 2009; 27(2):148-56. PubMed ID: 19546553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma].
    Chen MS; Zhang YJ; Li JQ; Liang HH; Zhang YQ; Zheng Y
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):623-5. PubMed ID: 16438875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Local treatment of liver tumors].
    Pless TK; Skjoldbye BO
    Ugeskr Laeger; 2008 Apr; 170(16):1348-9. PubMed ID: 18433596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic ultrasound-guided radiofrequency thermal ablation of hepatic tumors: a new coaxial approach.
    Salmi A; Metelli F
    Endoscopy; 2003 Sep; 35(9):802. PubMed ID: 12929042
    [No Abstract]   [Full Text] [Related]  

  • 7. Major complications of ultrasound-guided percutaneous radiofrequency ablations for liver malignancies: single center experience.
    Chen TM; Huang PT; Lin LF; Tung JN
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e445-50. PubMed ID: 17683478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous ablation of hepatocellular carcinoma: state-of-the-art.
    Lencioni R; Cioni D; Crocetti L; Bartolozzi C
    Liver Transpl; 2004 Feb; 10(2 Suppl 1):S91-7. PubMed ID: 14762847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications of percutaneous therapy.
    Gillams AR
    Cancer Imaging; 2005 Sep; 5(1):110-3. PubMed ID: 16305947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.
    Atwell TD; Charboneau JW; Que FG; Rubin J; Lewis BD; Nagorney DM; Callstrom MR; Farrell MA; Pitot HC; Hobday TJ
    Cardiovasc Intervent Radiol; 2005; 28(4):409-21. PubMed ID: 16041556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transthoracic percutaneous radiofrequency ablation for liver tumors in the hepatic dome.
    Shibata T; Shibata T; Maetani Y; Kubo T; Itoh K; Togashi K; Hiraoka M
    J Vasc Interv Radiol; 2004 Nov; 15(11):1323-7. PubMed ID: 15525754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of combined percutaneous radio-frequency ablation and percutaneous ethanol injection after transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhang FJ; Wu PH; Zhao M; Gu YK; Zhang L; Tan ZB
    Zhonghua Zhong Liu Za Zhi; 2005 Apr; 27(4):248-50. PubMed ID: 15949431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time" approach.
    Figueras J; Lladó L
    Cancer; 2003 Nov; 98(10):2303-4; author reply 2304-5. PubMed ID: 14601104
    [No Abstract]   [Full Text] [Related]  

  • 14. Image-guided thermal ablation of nonresectable hepatic tumors using the Cool-Tip radiofrequency ablation system.
    Schirmang TC; Dupuy DE
    Expert Rev Med Devices; 2007 Nov; 4(6):803-14. PubMed ID: 18035946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity did not diminish the efficacy of percutaneous ablation for hepatocellular carcinoma.
    Ohki T; Tateishi R; Shiina S; Sato T; Masuzaki R; Yoshida H; Kanai F; Obi S; Yoshida H; Omata M
    Liver Int; 2007 Apr; 27(3):360-7. PubMed ID: 17355458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image guided tumour ablation.
    Gillams AR
    Cancer Imaging; 2005 Sep; 5(1):103-9. PubMed ID: 16305946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm.
    Vallone P; Catalano O; Izzo F; Siani A
    Cardiovasc Intervent Radiol; 2006; 29(4):544-51. PubMed ID: 16528626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin release during percutaneous radiofrequency ablation in a patient with symptomatic liver metastases of a neuroendocrine tumor.
    Wettstein M; Vogt C; Cohnen M; Brill N; Kurz AK; Mödder U; Häussinger D
    Hepatogastroenterology; 2004; 51(57):830-2. PubMed ID: 15143927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transpulmonary CT-guided radiofrequency ablation of liver metastasis.
    Shankar S; Bhargava P; Habib F; Desai M; Tyagi G; Whalen G
    Cardiovasc Intervent Radiol; 2005; 28(4):481-4. PubMed ID: 16001134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].
    Xu ZM; Wang JH; Zhen ZJ; Chen HW; Cui WZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1626-8. PubMed ID: 17121718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.